WallStSmart

Covista Inc. (CVSA)vsStride Inc (LRN)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Stride Inc generates 27% more annual revenue ($2.54B vs $2.00B). LRN leads profitability with a 13.2% profit margin vs 12.8%. LRN appears more attractively valued with a PEG of 0.42. CVSA earns a higher WallStSmart Score of 73/100 (B).

CVSA

Strong Buy

73

out of 100

Grade: B

Growth: 7.3Profit: 7.5Value: 7.0Quality: 6.0
Piotroski: 4/9Altman Z: 3.06

LRN

Strong Buy

66

out of 100

Grade: B-

Growth: 5.3Profit: 7.0Value: 8.7Quality: 8.0
Piotroski: 4/9Altman Z: 4.25
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CVSA.

LRNUndervalued (+11.0%)

Margin of Safety

+11.0%

Fair Value

$87.39

Current Price

$74.58

$12.81 discount

UndervaluedFair: $87.39Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CVSA5 strengths · Avg: 8.4/10
Altman Z-ScoreHealth
3.0610/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.888/10

Growing faster than its price suggests

P/E RatioValuation
14.7x8/10

Attractively priced relative to earnings

Price/BookValuation
2.6x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.1%8/10

Strong operational efficiency at 20.1%

LRN4 strengths · Avg: 9.5/10
PEG RatioValuation
0.4210/10

Growing faster than its price suggests

P/E RatioValuation
10.4x10/10

Attractively priced relative to earnings

Altman Z-ScoreHealth
4.2510/10

Safe zone — low bankruptcy risk

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

Areas to Watch

CVSA0 concerns · Avg: 0/10

No major concerns identified

LRN3 concerns · Avg: 3.3/10
Revenue GrowthGrowth
3.0%4/10

3.0% revenue growth

EPS GrowthGrowth
3.6%4/10

3.6% earnings growth

Free Cash FlowQuality
$-149.27M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : CVSA

The strongest argument for CVSA centers on Altman Z-Score, PEG Ratio, P/E Ratio. Revenue growth of 10.7% demonstrates continued momentum. PEG of 0.88 suggests the stock is reasonably priced for its growth.

Bull Case : LRN

The strongest argument for LRN centers on PEG Ratio, P/E Ratio, Altman Z-Score. PEG of 0.42 suggests the stock is reasonably priced for its growth.

Bear Case : CVSA

No major red flags identified for CVSA, but monitor valuation.

Bear Case : LRN

The primary concerns for LRN are Revenue Growth, EPS Growth, Free Cash Flow.

Key Dynamics to Monitor

CVSA carries more volatility with a beta of 0.66 — expect wider price swings.

CVSA is growing revenue faster at 10.7% — sustainability is the question.

CVSA generates stronger free cash flow (76M), providing more financial flexibility.

Monitor EDUCATION & TRAINING SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CVSA scores higher overall (73/100 vs 66/100) and 10.7% revenue growth. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Stride Inc

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Stride, Inc., a technology-based education company, provides its own and third-party online educational services, software systems and curricula to facilitate individualized learning for students primarily in kindergarten through grade 12 (K -12) in the United States and internationally. .

Visit Website →

Want to dig deeper into these stocks?